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MeasuringValue in PrimaryCare:
EnhancingQuality orChecking the Box?
Over the last three decades, numerous health care process measures and surro-
gate health outcome measures have exploded onto the scene, often driven by
payers wanting to show commitment to “value.” With increasing popularity of
pay-for-performance and other value-based incentive programs aimed at maxi-
mizing quality while minimizing costs, primary care practices are confronted
with an ever-increasing sea of quality metrics that they are urged to satisfy. In
our health system at the University of Michigan, Blue Cross Blue Shield—a
payer that spends one in ﬁve medical claim dollars on value-based payment
arrangements—incentivizes at least 200 different quality metrics (Abelson
2014). Primary care physicians (PCPs) constantly chase this dizzying array of
metrics, recognizing that such measures frequently fail to help them care for
their sickest, most vulnerable patients. When seeing a homeless patient with
uncontrolled diabetes and food insecurity, for example, recording their smok-
ing history seems less pressing. Time spent at a practice on such “quality met-
rics” diverts from addressing the highest priority areas for the patient—areas
that often do not have a quality checkbox from a payer. PCPs face this tension
daily in balancing “checkbox” care that supposedly achieves high “quality”
with the actual clinical value they strive to provide vulnerable patients.
Aligning health care payments with quality measurement has long
been promoted as a vehicle for achieving higher quality of care (2001), but
which existing metrics, if any, truly measure quality? For example, does the
mere documentation of smoking status equate to quality? What if the
patient does not want to follow the advice of the physician? Is the physician
providing bad quality care? Should the physician be paid less? If the goal is
ultimately to improve health, quality must be measured as meaningful
health improvement, recognizing the role patients play in the interaction,
and incentivized accordingly.
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Measuring and reporting quality has been a challenge as quality scores
were ﬁrst publicly reported for surgeons performing coronary artery bypass
grafting (CABG) in New York. Despite widespread enthusiasm for this type of
quality measurement and reporting, there is concern that such programs may
actually penalize physicians caring for medically and psychosocially complex
patients (Hofer et al. 1999). In the case of CABG ratings, physicians may have
been incentivized to “dump” their sicker patients (Werner and Asch 2005).
Similarly, PCPs may be willing to ﬁre patients who do not comply with their
medical recommendations (Farber et al. 2008). This dumping behavior is
actually encouraged by incentive programs that promote compliance with
simple quality metrics but fail to account for the complex interventions neces-
sary for care of high-risk patients. The unintended consequence may be
decreased access to care, lower quality of care—or both—for many vulnerable
patients with multiple chronic conditions or difﬁcult socioeconomic circum-
stances (McMahon, Hofer, and Hayward 2007). Thus, the challenge health
services researchers face today is determining how best to use performance
measures to incentivize health care quality for those who need it most.
In this issue of Health Services Research, Jason Wang and colleagues
offer a notable case study of three overlapping incentive programs promot-
ing quality improvement in a network of small primary care practices in
New York City. They examine the impact of meaningful use, patient-cen-
tered medical home (PCMH) and pay-for-performance incentives on seven
quality metrics comprising both process and outcome measures related to
smoking, obesity, blood pressure, blood sugar, and vascular disease man-
agement. Practices participating in all three programs demonstrated
improvement in the study’s chosen quality metrics during the follow-up
period between 2009 and 2012, with PCMH practices achieving improve-
ment on the greatest number of measures. However, each program chose
different quality measures to incentivize, leading to potential complexity
and confusion during implementation in individual practices. While there
was observed improvement in some clinically relevant metrics such as
delivery of smoking cessation interventions, other “quality improvements”
were largely driven by process measures that do not directly impact patient
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outcomes, such as the simple documentation of smoking status and body
mass index. Focusing on identifying which incentive programs most effec-
tively drive improvements in quality metrics overlooks a more fundamental
issue—how do we meaningfully measure quality in primary care?
Health services researchers have measured quality at various levels, but
commonly in ways that are not clinically relevant. First, we have recorded
whether a health care process is done or not done—these checklist-like process
measures are not nuanced, but are relatively easy to measure and improve
(often by increasing documentation alone). Second, we have evaluated health
outcome measures. Given the long follow-up required to obtain meaningful
outcomes such as disability and mortality, we have more often assessed surro-
gate measures of health, such as hemoglobin A1C for diabetes control. These
intermediate outcomes often employ arbitrary cut-offs and rarely take into
account which patients would beneﬁt most from chronic disease management
such as blood sugar lowering in diabetes (Kerr et al. 2003). For example, a dia-
betic patient with a high baseline hemoglobin A1C (severe disease) may bene-
ﬁt more from aggressive blood sugar lowering, even if he or she never meets
an arbitrary cut-off of a hemoglobin A1C less than 7–8 (recommended dia-
betic control) (Vijan, Hofer, and Hayward 1997). Setting an arbitrary goal
blood glucose target for the whole population may disincentivize primary care
providers from caring for high-risk patients who would beneﬁt most from dis-
ease management. Even what we once thought were the best measures to in-
centivize—for example, low density lipoprotein—often turn out to be the
wrong target and have to be revisited (Hayward et al. 2010; Smith andGrundy
2014). Thus, it is unclear whether either process or outcome measures target
the right goal (Kerr et al. 2001). To improve population health, we need more
clinically nuancedmeasurements of quality that weight the value of high-prior-
ity care more and low-priority care less (McMahon andHeisler 2008).
It is time to abandon the one-size-ﬁts-all approach that we know does
not work. Instead we need to advance quality improvement metrics to the
next level by using population-based modeling to incentivize approaches
aimed at achieving the greatest health improvements in primary care prac-
tices, as determined by patients and their primary care providers. We could
utilize the vast amount of “big data” available in health systems to decide
which patients to target and how to optimally improve health outcomes in
a given population. This would entail use of multivariable risk assessment
and stratiﬁcation to identify high-risk subgroups of patients that are most
likely to beneﬁt from certain interventions (McMahon et al. 2005). Practices
could tailor quality improvement programs to their local population and in-
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centivize what is most valuable to improving their patients’ health. Few
populations could beneﬁt more from such health improvement than low-
income individuals with Medicaid or medically complex patients. Many
Medicaid managed care plans have actually employed such modeling to
target high-risk patients for care management programs (2008). Other plans
and health systems may similarly use the wealth of data available to them
to create tailored programs for their high-risk patients.
AsWang et al. mention in their article, recording of risk factors is a “crit-
ical ﬁrst step in prevention of adverse outcomes.” However, this one step is
not sufﬁcient to improve quality in primary care. With advances in predictive
modeling and increasing availability of electronic health information, we can
do much more to meaningfully improve care delivery. We need to take the
next step of population-based risk stratiﬁcation and tailored interventions that
provide true clinical value to vulnerable patients who need care most. It is
time to stop incentivizing checkboxmedicine and to start incentivizing health.
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